Contrasting Anti-obesity Effects of Smectite Clays and Mesoporous Silica in Sprague-Dawley Rats.

anti-obesity fat digestion functional foods lipolysis obesity

Journal

ACS applied bio materials
ISSN: 2576-6422
Titre abrégé: ACS Appl Bio Mater
Pays: United States
ID NLM: 101729147

Informations de publication

Date de publication:
16 Nov 2020
Historique:
entrez: 12 1 2022
pubmed: 16 11 2020
medline: 16 11 2020
Statut: ppublish

Résumé

Porous colloids have been shown to exert unique bioactivities for mediating lipid (fat) metabolism and thereby offer significant potential as anti-obesity therapies. In this study, we compare the capacity for two classes of colloids, that is, smectite clays (Laponite XLG, LAP; montmorillonite, MMT) and mesoporous silica (SBA-15 ordered silica; MPS), to impede intestinal lipid hydrolysis and provoke lipid and carbohydrate excretion through adsorption within their particle matrices. A two-stage

Identifiants

DOI: 10.1021/acsabm.0c00969 PMID: 35019518
pubmed: 35019518
doi: 10.1021/acsabm.0c00969
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7779-7788

Auteurs

Paul Joyce (P)

UniSA Clinical & Health Sciences, University of South Australia, Adelaide 5000, South Australia, Australia.
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of South Australia, Adelaide 5000, South Australia, Australia.
ORCID: 0000-0003-3619-7901

Tahnee J Dening (TJ)

UniSA Clinical & Health Sciences, University of South Australia, Adelaide 5000, South Australia, Australia.
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of South Australia, Adelaide 5000, South Australia, Australia.
ORCID: 0000-0003-0676-1444

Tahlia R Meola (TR)

UniSA Clinical & Health Sciences, University of South Australia, Adelaide 5000, South Australia, Australia.
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of South Australia, Adelaide 5000, South Australia, Australia.

Anthony Wignall (A)

UniSA Clinical & Health Sciences, University of South Australia, Adelaide 5000, South Australia, Australia.
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of South Australia, Adelaide 5000, South Australia, Australia.

Hanna Ulmefors (H)

UniSA Clinical & Health Sciences, University of South Australia, Adelaide 5000, South Australia, Australia.
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of South Australia, Adelaide 5000, South Australia, Australia.

Miia Kovalainen (M)

Research Unit of Biomedicine and Biocenter of Oulu, Faculty of Medicine, University of Oulu, P.O. Box 5000, Oulu FI-90014, Finland.

Clive A Prestidge (CA)

UniSA Clinical & Health Sciences, University of South Australia, Adelaide 5000, South Australia, Australia.
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of South Australia, Adelaide 5000, South Australia, Australia.
ORCID: 0000-0001-5401-7535

Classifications MeSH